A fixed-dose combo with BP-lowering meds, statin and aspirin yields the largest reduction in cardiovascular risk.
Moderna says omicron-specific booster should be ready by August
Jun 23, 2022
The vaccine targets both omicron and the original strain of the virus.
Post-COVID conditions are common among adult survivors
May 25, 2022
There was a more than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64 and ≥65 years.
High AI-ECG-AF risk score tied to worse cognition, cognitive decline
May 11, 2022
A high probability of atrial fibrillation by AI-ECG-AF score correlated with cerebral infarcts on MRI.
Health-related quality of life on the decline preceding initiation of dialysis for seniors
Jul 29, 2022
In the year following the start of dialysis, stabilization with mean changes of +2 and –2 were seen in mental and physical component summaries.
Adding a P2Y12 inhibitor does not improve outcomes in COVID-19
Jan 18, 2022
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19.
Cemented hemiarthroplasty for hip fracture improves QOL for those 60 and older
Feb 10, 2022
A modest improvement in quality of life and fewer periprosthetic fractures were seen in patients receiving cemented versus uncemented hemiarthroplasty.
CV, cancer risk up with tofacitinib for rheumatoid arthritis
Jan 28, 2022
Incidences of major adverse cardiovascular events and cancers were higher with tofacitinib versus a TNF inhibitor; criteria for noninferiority were not met.
Polypill cuts cardiovascular event risk in seniors with recent MI
Aug 30, 2022
A polypill comprising aspirin, ramipril and atorvastatin is effective for secondary prevention of cardiovascular disease in older adults.